Adeno-Associated Virus– tag –
-
Australia’s VVMF Sydney Facility Secures TGA GMP License for Gene and Cell Therapy Manufacturing, Bolstering Domestic CDMO Capacity
Contract Pharma USA Overview Australia's Viral Vector Manufacturing Facility (VVMF) has officially received a Therapeutic Goods Administration (TGA) GMP license for therapeutic product manufacturing at its Sydney site, effective Septembe... -
Viral Vector Packaging Services Market Signals Rapid Growth Driven by Gene Therapy Commercialization and Increased Biomanufacturing Investment
openPR.com USA Overview This article provides an overview of a market research report from openPR.com. The global viral vector packaging services market is experiencing rapid growth, driven by advancing gene therapy commercialization and... -
CDMO Signal Ranks Viral Vector CDMOs: Thermo Fisher Scientific, AGC Biologics, and Takeda Lead Top Tier
CDMO Signal USA Overview CDMO Signal released its latest ranking of viral vector CDMOs, including AAV, lentiviral, and adenoviral modalities. Thermo Fisher Scientific, AGC Biologics, and Takeda secured top positions in the overall Signal... -
AGC Biologics Highlights Strengths as Global CDMO Partner for Biologics and Advanced Therapies
The Economy Global Overview AGC Biologics is recognized as a global biopharmaceutical CDMO providing development and manufacturing services across a wide range of advanced modalities, including biologics, plasmid DNA, mRNA, viral vectors... -
4basebio and Genezen Partner to Revolutionize Viral Vector Manufacturing: hpDNA Boosts AAV Titers by up to 33-fold
AllSci Overview 4basebio and Genezen have announced a strategic collaboration to integrate 4basebio's hpDNA platform into viral vector manufacturing workflows, aiming to significantly enhance efficiency. This innovative cell-free synthet... -
Bioprocess Insider Reports AI Tools Revolutionize Antibody Design, Viral Titer Measurement, and Workforce Readiness in Minutes, Optimizing Gene Therapy Manufacturing
Bioprocess Insider UK Overview Bioprocess Insider reports that AI tools are driving extensive innovations in bioprocessing, with GeneData presenting an end-to-end optimization platform and BioCurie developing real-time rAAV (recombinant ... -
4basebio and Genezen Partnership Revolutionizes Viral Vector Manufacturing: Cell-Free Synthetic DNA Reduces Costs by 30%
BioPharm International USA Overview 4basebio and viral vector CDMO Genezen announced a partnership to integrate 4basebio's cell-free hpDNA platform into Genezen's manufacturing workflow. This innovative technology enzymatically produces ... -
Ultragenyx’s Gene Therapy GENGLYCOS™ for Glycogen Storage Disease Type 1a Receives US FDA Accelerated Approval
RegMedNet USA Overview The US FDA has granted accelerated approval to Ultragenyx Pharmaceuticals' gene therapy, GENGLYCOS™, for adult and pediatric patients aged 8 and older with Glycogen Storage Disease Type 1a (GSD1a). GSD1a is an ultr... -
Virica Biotech Announces CAR-T Lentivirus Manufacturing Innovations and AAV Production Optimization with FUJIFILM
Virica Biotech Canada Overview Virica Biotech has announced innovative advancements in lentiviral vector manufacturing for CAR-T therapies, highlighted by a May 19, 2026, poster presentation featuring high productivity and smarter purifi... -
PackGene Biotech’s π-alpha 293 Platform Achieves 10x AAV Production Amplification, Up to 1e+17vg/Batch, Supporting Remedium Bio’s Gene Therapy Advancement
PackGene Biotech China Overview PackGene Biotech announced its innovative π-alpha 293 AAV high-yield platform, capable of amplifying adeno-associated virus (AAV) production up to 10-fold and achieving an impressive yield of up to 1e+17vg...
